In human medicine, it is demonstrated that some of the mineral metabolites’ abnormalities detected in CKD are also common during AKI: hypocalcemia, hyperparathyroidism (HPT), hyperphosphatemia, decreased vitamin D, increased FGF-23 levels and decreased renal Klotho expression [18]. This evidence concerns the gene FGF23 and chronic kidney disease.